Challenges Facing Prostate Cancer Equity


Brandon Mahal, MD, discusses challenges facing prostate cancer equity.

Brandon Mahal, MD, an assistant professor at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, discusses challenges facing prostate cancer equity.

According to Mahal, there are only 3 well-established prostate cancer risk factors: age, family history, and race. Mahal notes that while race is a social construct, the factors driving race such as culture and environmental influences are very real. They inform race, which creates the social structure.

In order to better understand prostate cancer risk factors, we must better understand race, according to Mahal. It shouldn’t be that race is the underlying driving factor, but what is driving race, such as the environment and structural racism. According to Mahal, physicians must themselves to understand the factors driving race. By doing so, the field will have better knowledge around what drives prostate cancer risk.

Related Videos
Video 8 - "Clinical Pearls for Optimal Management of mHSPC"
Video 7 - "Multidisciplinary Approach in mHSPC Management "
Video 6 - "Treatment Considerations in High Disease Burden and Comorbidities"
Video 5 - "Pivotal Trials in mHSPC"
Video 4 - "ARASENS Trial- Darolutamide in mHSPC"
Video 3 - "Treatment Intensification in Metastatic Prostate Cancer"
Video 2 - "Treatment Options for mHSPC"
Video 1 - "Initial Impression and Risk Assessment"
Video 5 - "Addressing Unmet Needs and Final Perspectives on nmCRPC"
Video 4 - "Integrating ARAMIS Trial Data and Managing Adverse Events in nmCRPC Treatment"
Related Content